| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/03/1997 | EP0792641A1 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 09/03/1997 | EP0792640A2 Use of (E)-1-(4'-(2-alkylaminoethioxy)-phenyl)-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes for inhibiting pathological conditions |
| 09/03/1997 | EP0792639A1 Combination therapy to treat osteoporosis or conditions which present low bone mass |
| 09/03/1997 | EP0792370A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
| 09/03/1997 | EP0792364A2 Lgmd gene coding for a calcium dependent protease |
| 09/03/1997 | EP0792360A2 Proteins involved in the regulation of cell-cell adhesion and uses thereof |
| 09/03/1997 | EP0792291A1 Protein affecting katp channels |
| 09/03/1997 | EP0792278A1 Tumor necrosis factor-gamma |
| 09/03/1997 | EP0792265A1 Endothelin antagonists |
| 09/03/1997 | EP0792163A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
| 09/03/1997 | EP0792158A1 Use of angiotensin ii fragments and analogs thereof in tissue repair |
| 09/03/1997 | EP0792154A1 Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 09/03/1997 | EP0792153A1 Compositions containing lazaroids and their use for preventing adhesions |
| 09/03/1997 | EP0792150A1 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| 09/03/1997 | EP0792149A2 Oral compositions containing ondansetron |
| 09/03/1997 | EP0656905B1 Calcium channel blocking polypeptide from agelenopsis aperta |
| 09/03/1997 | EP0639178B1 Anti-atherosclerotic aryl compounds |
| 09/03/1997 | CN1158639A DNA sequences coding for the human proteins TX and TY related to the interleukin-IBeta converting enzyme |
| 09/03/1997 | CN1158615A Bicyclic carboxamides as 5-ht1A antagonists |
| 09/03/1997 | CN1158613A Novel use and noveld erivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 09/03/1997 | CN1158612A Novel substituted piperidines useful for the treatment of allergic diseases |
| 09/03/1997 | CN1158608A Certain aminomethyl phenylidazole derivatives, a new class of dopamine receptor subtype specific ligands |
| 09/03/1997 | CN1158571A Remedy for endotoxinemia andmultiple organ failure induced thereby |
| 09/03/1997 | CN1158566A Pharmaceutical compsn. for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for treatment thereof |
| 09/03/1997 | CN1035768C 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase |
| 09/02/1997 | US5663448 Treating alzheimer*s disease |
| 09/02/1997 | US5663417 Carbocyclic sulfonamides |
| 09/02/1997 | US5663380 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 09/02/1997 | US5663375 Cell proliferation |
| 09/02/1997 | US5663367 Regulator of cell proliferation and differentiation; treatment of skin disorders, antiinflammatory agents, anticarcinogenic agents |
| 09/02/1997 | US5663364 Heme binding compounds and use thereof |
| 09/02/1997 | US5663357 Substituted heteroarylamides having retinoid-like biological activity |
| 09/02/1997 | US5663352 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
| 09/02/1997 | US5663350 Process for the preparation of intermediates useful for the synthesis of histamine receptor antagonists |
| 09/02/1997 | US5663349 Multistage process of reduction and amination of aminopyridines |
| 09/02/1997 | US5663343 Process for the preparation of enantiomerically pure imidazolyl compounds |
| 09/02/1997 | US5663334 Process for preparing pyrimidyl imidazoles |
| 09/02/1997 | US5663322 Precipitation |
| 09/02/1997 | US5663208 Pyruvic acid comppounds, antioxidants and fatty acids |
| 09/02/1997 | US5663202 Administering gamma-linolenic acid to reduce damage to gastrointestinal and nervous system during radiation therapy |
| 09/02/1997 | US5663191 Psychiatric diseases, anxiety and antidepressants |
| 09/02/1997 | US5663187 Treatment of atherosclerosis with angiotensin II receptor blocking imidazoles |
| 09/02/1997 | US5663186 Treatment of atherosclerosis with angiotensin II receptor blocking imidazoles |
| 09/02/1997 | US5663174 Antiinflammatory agents, inhibitor of kinases, antiarthritic agents |
| 09/02/1997 | US5663173 Central nervous system disorders, cognition activators, pychoses, antidepressants and eating disorders |
| 09/02/1997 | US5663171 For use in humans or animals |
| 09/02/1997 | US5663151 Sulfated α-glycolipid derivatives as cell adhesion inhibitors |
| 09/02/1997 | US5663071 An isolated polynucleotide |
| 09/02/1997 | US5662934 Vitamins, gemfibrozil |
| 09/02/1997 | US5662918 Bone disorders, storage stable |
| 09/02/1997 | US5662904 Anti-scarring compositions comprising growth factor neutralizing antibodies |
| 09/02/1997 | US5662900 Method of increasing interferon production in humans |
| 08/28/1997 | WO1997031113A1 Cell-based assay |
| 08/28/1997 | WO1997031010A1 Receptor protein designated 2f1 |
| 08/28/1997 | WO1997031003A1 Camptothecin derivatives and the use thereof as antitumor agents |
| 08/28/1997 | WO1997030999A1 Quinolones and their therapeutic use |
| 08/28/1997 | WO1997030992A1 Inhibitors of farnesyl protein transferase |
| 08/28/1997 | WO1997030990A1 Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/28/1997 | WO1997030989A1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/28/1997 | WO1997030707A1 NON-PEPTIDYL VASOPRESSIN V1a ANTAGONISTS |
| 08/28/1997 | WO1997030704A2 Use of carbonic anhydrase inhibitors for treating macular edema |
| 08/28/1997 | WO1997019679A3 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 08/28/1997 | WO1997019669A3 Heterocyclic compounds and their use |
| 08/28/1997 | CA2246300A1 Cell-based assay |
| 08/28/1997 | CA2242598A1 Quinolones and their therapeutic use |
| 08/28/1997 | CA2198574A1 Combination therapy to prevent bone loss-progesterone and estrogen agonists |
| 08/28/1997 | CA2198571A1 Use of (e)-1-¬4'-(2-alkylaminoethioxy)phenyl|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions |
| 08/28/1997 | CA2198534A1 Combination therapy to treat osteoporosis - polyphosphonates or progestins and estrogen agonists |
| 08/27/1997 | EP0791601A2 An agent promoting bone formation and inhibiting bone resorption |
| 08/27/1997 | EP0791594A2 2-Aryl-5,11-dihydro-6H-dipyrido 3,2-b:2',3'-e 1,4 diazepines and their use for the preparation of pharmaceutical compositions for the treatment of HIV infection |
| 08/27/1997 | EP0791592A2 Azetidines |
| 08/27/1997 | EP0791577A1 Ortho-substituted benzylguanidines, process for their preparation and their use as medicament or diagnostic agent as well as medicament containing them |
| 08/27/1997 | EP0791576A2 Leukotriene antagonistic benzoic acid derivatives |
| 08/27/1997 | EP0791359A1 Remedy for diseases caused by il-6 production |
| 08/27/1997 | EP0791356A1 Combinations of droloxifene with progestins for the treatment of osteoporosis |
| 08/27/1997 | EP0791355A1 Method of reducing tissue damage associated with ischemia |
| 08/27/1997 | EP0791298A1 Growth promotion in chickens |
| 08/27/1997 | EP0791068A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 08/27/1997 | EP0791056A2 Lipid-splitting enzyme |
| 08/27/1997 | EP0791011A2 Biologically active tgf-beta1 and tgf-beta2 peptides |
| 08/27/1997 | EP0791009A1 Modified neuropeptide y receptors |
| 08/27/1997 | EP0791006A2 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 08/27/1997 | EP0791005A1 Smooth muscle cell proliferation inhibitors |
| 08/27/1997 | EP0791004A1 Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 08/27/1997 | EP0790999A1 Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments |
| 08/27/1997 | EP0790997A2 6-ARYL PYRIDO( 2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 08/27/1997 | EP0790993A1 Nonpeptide endothelin antagonists |
| 08/27/1997 | EP0790987A1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 08/27/1997 | EP0790974A1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/27/1997 | EP0790831A1 Method for reducing the severity of gastro-intestinal damage |
| 08/27/1997 | EP0790826A1 Dihydropyrimidines and uses thereof |
| 08/27/1997 | EP0790825A1 Nk-1 receptor antagonists for the treatment of eye disorders |
| 08/27/1997 | EP0679152B1 Anti-androgenic cyclo and bicyclo alkenes |
| 08/27/1997 | EP0647231B1 N-substituted 3-azabicyclo[3.2.0]heptane derivatives useful as neuroleptic agents, etc. |
| 08/27/1997 | EP0592438B1 Indole derivatives |
| 08/27/1997 | EP0575454B1 Use of cucurbitine for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergic composition and method involving application thereof |
| 08/27/1997 | EP0560845B1 Cell proliferation matrix and use thereof |
| 08/27/1997 | EP0531425A4 Wound healing |
| 08/27/1997 | EP0520005B1 Nitroxides for weight reduction |
| 08/27/1997 | EP0460116B1 9-substituted-8-unsubstituted-9-deazaguanines |